BACKGROUND: Anthracyclines are important chemotherapeutic agents, but their use is limited by cardiotoxicity. Candidate gene and genome-wide studies have identified putative risk loci for overt cardiotoxicity and heart failure, but there has been no comprehensive assessment of genomic variation influencing the intermediate phenotype of anthracycline-related changes in left ventricular (LV) function. The purpose of this study was to identify genetic factors influencing changes in LV function after anthracycline chemotherapy. METHODS: We conducted a genome-wide association study (GWAS) of change in LV function after anthracycline exposure in 385 patients identified from BioVU, a resource linking DNA samples to de-identified electronic medical record data. Variants with P values less than 1×10 were independently tested for replication in a cohort of 181 anthracycline-exposed patients from a prospective clinical trial. Pathway analysis was performed to assess combined effects of multiple genetic variants. RESULTS: Both cohorts were middle-aged adults of predominantly European descent. Among 11 candidate loci identified in discovery GWAS, one single nucleotide polymorphism near PR domain containing 2, with ZNF domain (PRDM2), rs7542939, had a combined P value of 6.5×10 in meta-analysis. Eighteen Kyoto Encyclopedia of Gene and Genomes pathways showed strong enrichment for variants associated with the primary outcome. Identified pathways related to DNA repair, cellular metabolism, and cardiac remodeling. CONCLUSION: Using genome-wide association we identified a novel candidate susceptibility locus near PRDM2. Variation in genes belonging to pathways related to DNA repair, metabolism, and cardiac remodeling may influence changes in LV function after anthracycline exposure.
BACKGROUND: Anthracyclines are important chemotherapeutic agents, but their use is limited by cardiotoxicity. Candidate gene and genome-wide studies have identified putative risk loci for overt cardiotoxicity and heart failure, but there has been no comprehensive assessment of genomic variation influencing the intermediate phenotype of anthracycline-related changes in left ventricular (LV) function. The purpose of this study was to identify genetic factors influencing changes in LV function after anthracycline chemotherapy. METHODS: We conducted a genome-wide association study (GWAS) of change in LV function after anthracycline exposure in 385 patients identified from BioVU, a resource linking DNA samples to de-identified electronic medical record data. Variants with P values less than 1×10 were independently tested for replication in a cohort of 181 anthracycline-exposed patients from a prospective clinical trial. Pathway analysis was performed to assess combined effects of multiple genetic variants. RESULTS: Both cohorts were middle-aged adults of predominantly European descent. Among 11 candidate loci identified in discovery GWAS, one single nucleotide polymorphism near PR domain containing 2, with ZNF domain (PRDM2), rs7542939, had a combined P value of 6.5×10 in meta-analysis. Eighteen Kyoto Encyclopedia of Gene and Genomes pathways showed strong enrichment for variants associated with the primary outcome. Identified pathways related to DNA repair, cellular metabolism, and cardiac remodeling. CONCLUSION: Using genome-wide association we identified a novel candidate susceptibility locus near PRDM2. Variation in genes belonging to pathways related to DNA repair, metabolism, and cardiac remodeling may influence changes in LV function after anthracycline exposure.
Authors: Pratima Malekar; Marco Hagenmueller; Adamma Anyanwu; Sebastian Buss; Marcus R Streit; Celine S Weiss; David Wolf; Johannes Riffel; Alexander Bauer; Hugo A Katus; Stefan E Hardt Journal: Hypertension Date: 2010-02-22 Impact factor: 10.190
Authors: Javier G Blanco; Can-Lan Sun; Wendy Landier; Lu Chen; Diego Esparza-Duran; Wendy Leisenring; Allison Mays; Debra L Friedman; Jill P Ginsberg; Melissa M Hudson; Joseph P Neglia; Kevin C Oeffinger; A Kim Ritchey; Doojduen Villaluna; Mary V Relling; Smita Bhatia Journal: J Clin Oncol Date: 2011-11-28 Impact factor: 44.544
Authors: Henk Visscher; Colin J D Ross; S Rod Rassekh; Amina Barhdadi; Marie-Pierre Dubé; Hesham Al-Saloos; George S Sandor; Huib N Caron; Elvira C van Dalen; Leontien C Kremer; Helena J van der Pal; Andrew M K Brown; Paul C Rogers; Michael S Phillips; Michael J Rieder; Bruce C Carleton; Michael R Hayden Journal: J Clin Oncol Date: 2011-09-06 Impact factor: 44.544
Authors: Leo E Otterbein; Andreas Hedblom; Clair Harris; Eva Csizmadia; David Gallo; Barbara Wegiel Journal: Proc Natl Acad Sci U S A Date: 2011-08-17 Impact factor: 11.205
Authors: Sui Zhang; Xiaobing Liu; Tasneem Bawa-Khalfe; Long-Sheng Lu; Yi Lisa Lyu; Leroy F Liu; Edward T H Yeh Journal: Nat Med Date: 2012-10-28 Impact factor: 53.440
Authors: Erica Bowton; Julie R Field; Sunny Wang; Jonathan S Schildcrout; Sara L Van Driest; Jessica T Delaney; James Cowan; Peter Weeke; Jonathan D Mosley; Quinn S Wells; Jason H Karnes; Christian Shaffer; Josh F Peterson; Joshua C Denny; Dan M Roden; Jill M Pulley Journal: Sci Transl Med Date: 2014-04-30 Impact factor: 17.956
Authors: Praphulla C Shukla; Krishna K Singh; Adrian Quan; Mohammed Al-Omran; Hwee Teoh; Fina Lovren; Liu Cao; Ilsa I Rovira; Yi Pan; Christine Brezden-Masley; Bobby Yanagawa; Aanika Gupta; Chu-Xia Deng; John G Coles; Howard Leong-Poi; William L Stanford; Thomas G Parker; Michael D Schneider; Toren Finkel; Subodh Verma Journal: Nat Commun Date: 2011-12-20 Impact factor: 14.919
Authors: Quinn S Wells; Deepak K Gupta; J Gustav Smith; Sean P Collins; Alan B Storrow; Jane Ferguson; Maya Landenhed Smith; Jill M Pulley; Sarah Collier; Xiaoming Wang; Dan M Roden; Robert E Gerszten; Thomas J Wang Journal: J Am Coll Cardiol Date: 2019-05-07 Impact factor: 24.094
Authors: Yadav Sapkota; Matthew J Ehrhardt; Na Qin; Zhaoming Wang; Qi Liu; Weiyu Qiu; Kyla Shelton; Ying Shao; Emily Plyler; Heather L Mulder; John Easton; J Robert Michael; Paul W Burridge; Xuexia Wang; Carmen L Wilson; John L Jefferies; Eric J Chow; Kevin C Oeffinger; Lindsay M Morton; Chunliang Li; Jun J Yang; Jinghui Zhang; Smita Bhatia; Daniel A Mulrooney; Melissa M Hudson; Leslie L Robison; Gregory T Armstrong; Yutaka Yasui Journal: J Natl Cancer Inst Date: 2022-08-08 Impact factor: 11.816